Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2001, p. 1868-1871, Vol. 45, No. 6
Centre for Protein Engineering, University of
Liège, Institut de Chimie B6, Sart Tilman, 4000 Liège,1 and Laboratoire de
Biochimie Physique et des Biopolymeres, Université Catholique de
Louvain, Bâtiment Lavoisier, 1348 Louvain-la-Neuve,4 Belgium; Fachrichtung
8.8 Biochemie, Universität des Saarlandes, D-66123
Saarbrücken, Germany2;
Dipartimento di Biologia Molecolare, Sezione di
Microbiologia, Università di Siena, I-53100 Siena,
Italy3; and Department of Chemistry,
Wesleyan University, Middletown, Connecticut 064595
Received 23 August 2000/Returned for modification 13 December
2000/Accepted 2 March 2001
CENTA, a chromogenic cephalosporin, is readily hydrolyzed by
Nitrocefin and, to a lesser extent,
PADAC have been used as chromogenic substrates of
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.6.1868-1871.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
CENTA as a Chromogenic Substrate for Studying
-Lactamases
![]()
ABSTRACT
Top
Abstract
Text
References
-lactamases of all classes except for the Aeromonas
hydrophila metalloenzyme. Although it cannot practically be used
for the detection of
-lactamase-producing strains on agar plates, it should be quite useful for kinetic studies and the detection of the
enzymes in crude extracts and chromatographic fractions.
![]()
TEXT
Top
Abstract
Text
References
-lactamases. Such
substrates, whose hydrolysis can be directly monitored in the visible
wavelength range, are of particular interest for the kinetic
characterization of
-lactamases. Nitrocefin has, for instance, been
widely used as a reporter substrate in the study of the inactivation of
-lactamases or of their interactions with poor substrates
(3). It also allows the rapid identification of active
fractions during
-lactamase purification. However, the price of
nitrocefin has recently been increased significantly, and PADAC is no
longer commercially available. Synthesis of compounds is also rather
tedious. It is thus surprising that a third chromogenic cephalosporin,
CENTA (Fig. 1), which can be prepared
from the commercially available drug cephalothin, has not received more
attention, although it was shown to be sensitive to many
-lactamases
(11). In the study described in this report, we determined
the kinetic parameters characterizing the interactions between CENTA
and a representative set of
-lactamases and some penicillin-binding
proteins (PBPs). Although CENTA cannot be used for the direct detection
of
-lactamase-producing colonies on agar plates, it still represents
an interesting alternative to nitrocefin for the kinetic
characterization of
-lactamases.

View larger version (8K):
[in a new window]
FIG. 1.
Structure of CENTA.
CENTA was prepared as follows: 3-carboxyl-4-nitrothiophenol (TNB) was obtained by dissolving 5.05 mmol (2 g) of 5,5'-dithio-bis-(2-nitrobenzoic acid) in 100 ml of an aqueous solution of 0.5 M Tris base, and the pH was adjusted to 8.0 by addition of 6 M HCl. Dithiothreitol (7.1 mmol, 1.1 g) was added, and the solution turned orange-red. The mixture was stirred for 10 min at 22°C and extracted six times with 25 ml of ethyl acetate before being acidified to pH 1.5 by addition of 6 M HCl. The residual ethyl acetate was eliminated by bubbling nitrogen through the solution, which was thereafter left overnight at 4°C. The precipitate (TNB) was collected by filtration, washed, and dried. The sodium salt of cephalothin (1 g, 2.4 mmol) and 1 equivalent of TNB (478 mg) were dissolved in 19 ml of H2O, and the pH was adjusted to 7.0 with 1 M NaOH. The solution was stirred for 6 h at 65°C. The cooled solution was extracted with 10 ml of ethyl acetate, acidified to pH 2.0 with 1 M HCl, and extracted three times with 15 ml of ethyl acetate. The organic phase was washed three times with 15 ml of water, dried over MgSO4, and evaporated to dryness in vacuo. The sodium salt of CENTA was obtained by dissolving the dry residue in 25 ml of water containing 1 equivalent of NaHCO3, and the solution was freeze-dried, yielding 1.36 g of a light brown solid. Filtration through a Sephadex G-10 column did not modify the yield or improve the purity of the compound, as demonstrated by infrared spectroscopy (KBr) or nuclear magnetic resonance imaging at 200 MHz. The final yield was 1.31 g (94%, with respect to cephalothin).
CENTA was tested as a substrate for class A (TEM-1 [17],
NMCA [19], SHV-1 [1], TOHO-1
[10], Mycobacterium tuberculosis [22], Staphylococcus aureus
[21]), class B (Bacillus cereus [2], CphA [9], IMP-1 [12],
CfiA [16], BlaB [18], VIM-1 [5]), class
C (Enterobacter cloacae 908R [7],
Pseudomonas aeruginosa, Citrobacter freundii, and ACT-1),
and class D (OXA-10 [1], OXA-2 [13])
-lactamases and as an inactivator of the soluble form of the
Escherichia coli PBP 5 (20),
Streptomyces sp. R61 DD-peptidase
(8), Actinomadura sp. R39
DD-peptidase (8), and Streptomyces
sp. K15 DD-transpeptidase (14). All kinetic experiments with
-lactamases and PBP 5 were performed at 30°C in
50 mM sodium phosphate (pH 7.0) with 100 µM ZnSO4 added
for the B. cereus, IMP-1, and CfiA class B
metallo-
-lactamases. The hydrolysis of CENTA was monitored by
continuously recording the absorbance variation at 346 nm (
=
2,500 M
1 cm
1) or 405 nm (
= +6,400
M
1 cm
1). The kcat
and Km values were derived from initial rate
measurements with the help of the Hanes linearization of the
Henri-Michaelis equation and direct fitting on the hyperbolic equation
by nonlinear regression or from complete time courses (3).
The lowest Km values obtained with SHV-1, CfiA,
OXA-10, and OXA-2 were verified by using CENTA as a competitive
inhibitor versus 100 µM nitrocefin for the first three enzymes and
versus 300 µM cefaclor for the fourth one. The other experimental
conditions are detailed in Table 1.
|
Inactivation of the R61, R39, and K15 DD-peptidases was
monitored by incubating the enzymes with various concentrations of CENTA and measuring the residual activity of an aliquot after increasing periods of time. Activity was determined by measuring the
production of D-alanine from
N
,N
-diacetyl-L-lysyl-D-alanyl-D-alanine
by the D-amino acid oxidase method (6). In the
case of the K15 enzyme, the assay mixture also contained 10 mM
glycylglycine. The buffers were as follows: for R39, 50 mM Tris (pH
8.0) plus 1 mM MgCl2; for R61 and K15, 50 mM Tris (pH 8.0).
Table 1 summarizes the kinetic constants obtained with CENTA and the
various
-lactamases and compares them with those obtained with
nitrocefin. CENTA was a relatively good substrate of all the enzymes
with the sole exception of the CphA enzyme, which is very specific for
carbapenems and similarly exhibits very poor activity against
nitrocefin. The kinetic parameters of OXA-10 and SHV-1 with nitrocefin
were determined in the present work. When compared to nitrocefin, the
initial rates recorded at the same 100 µM concentration are of the
same order of magnitude with the exceptions of those for the OXA-10 and
SHV enzymes. One should be reminded, however, that the 
value of
CENTA (+6,400 M
1 cm
1) is significantly
lower than that of nitrocefin (+17,500 M
1
cm
1). Nonetheless, CENTA can easily be used for
monitoring the presence of all the enzymes (excepted CphA) in
chromatographic fractions and as a reporter substrate for detailed
kinetic studies even with enzymes (M. tuberculosis and
OXA-10) which exhibit rather low levels of activity against this
compound. The maximum change of absorbance of the leaving group is
different from that for most
-lactam antibiotics. Interestingly, and
in contrast to nitrocefin, hydrolysis of CENTA by the OXA-2 class D
enzyme does not exhibit the burst phenomenon which precludes the use of
the latter substrate in competition and reporter substrate experiments.
Although it was a poor substrate and inactivator of PBP 5 (kcat/Km = 22 M
1 s
1), the kcat
value was unexpectedly high for a PBP (5 × 10
3
s
1), reflecting a relatively rapid deacylation step
(>5 × 10
3 s
1). The
Km value was, accordingly, rather high (220 µM). With the Streptomyces sp. R61 and
Actinomadura sp. R39 enzymes, the second-order inactivation
rate constants were of the same order of magnitude as those observed
with cephalothin (2,000 ± 200 and 90,000 ± 10,000 M
1 s
1, respectively). Deacylation was very
slow in both cases (<10
4 s
1). Finally, the
K15 enzyme was not sensitive to CENTA
(k2/K' < 0.1 M
1
s
1), a result which reflects the low sensitivity of this
enzyme to cephalothin (k2/K' = 2 M
1 s
1 [14]).
Since the appearance of the chromophore is related to the expulsion of
the C-3' leaving group which is not concomitant with the opening of the
-lactam ring (4), it was important to verify that this
expulsion was sufficiently rapid so that no artifact would be
introduced in the measurement of initial rates or complete time
courses. To do so, CENTA (30 to 60 µM) was hydrolyzed at 30°C with
increasing concentrations of the E. cloacae 908R class C
-lactamase (0.03 to 20 µM). The variation in the absorbance was
monitored at 260 nm (hydrolysis of the endocyclic amide bond) or 405 nm
(appearance of the expulsed chromophore) for 1 to 80 s on a
stopped-flow spectrophotometer (Biologic SFM-3; Grenoble, France).
Figure 2 shows that a clear lag becomes
detectable in the curve for 405 nm when the reaction is completed
within about 1 s. From these data, it can be estimated that the
first-order rate constant characterizing the expulsion step is
5
s
1 and that, as a consequence, the rate of this reaction
is unlikely to influence the values of the rate constants derived from
complete time courses recorded over at least 1 min or from initial rate measurements performed over at least 30 s. Accordingly, the
increase in the A405 value was linear under
conditions in which about 5% of a 200 µM CENTA solution was
hydrolyzed in 1 min, and within the limits of experimental errors, the
initial rates were the same when derived from measurements obtained
when the absorbance was monitored at 405 or 260 nm.
|
The chemical properties of CENTA are also favorable. In contrast to
nitrocefin, whose stock solution must be prepared in dimethyl sulfoxide
or dimethylformamide, CENTA is highly soluble in aqueous buffers. At pH
7 and in 200 mM sodium phosphate buffer, it was soluble up to a final
concentration of 60 mg/ml. The stability of a 100 µM solution was
analyzed at a pH range of 4 to 12 at 25°C. The following buffers were
used: for pH 4 and 5, 50 mM sodium acetate-acetic acid; for pH 6, 10 mM
sodium cacodylate-HCl; for pH 7, 50 mM sodium phosphate; for pH 8, 10 mM Tris-HCl and 10 mM HEPES-NaOH; for pH 9 and 10, 50 mM CAPSO-NaOH;
for pH 11, 50 mM Na2HPO4-NaOH; for pH 12, 50 mM
KCl-NaOH. The absorbance at 405 nm was determined after increasing
periods of time. When the incubation was performed below pH 7, the
reading was made after adjustment of the pH of an aliquot to pH 7. Up
to pH 9, no significant spontaneous hydrolysis of CENTA could be
detected after a 60-min incubation. At higher pH values, the compound
was less stable and the hydrolysis rates constants were 0.7 × 10
5 s
1 at pH 11 and 1 × 10
3
s
1 at pH 12. At the latter pH, the rate of hydrolysis of
nitrocefin was 2.6 × 10
3 s
1.
Incubation of 100 µM CENTA in rabbit serum diluted fourfold at pH 7 and 30°C did not result in significant hydrolysis after 1 h,
whereas the half-life of nitrocefin was 13 min under the same
conditions (15). Similarly, at 30°C, substantial
aminolysis of CENTA was observed in the presence of 300 mM Tris-HCl (pH
8.0; half-life, 19 min [the half-life for nitrocefin is 38 min]), but no detectable degradation occurred in the same buffer at a 10 mM
concentration, in which nitrocefin exhibited a half-life of 380 min.
These experiments demonstrate that CENTA is a readily obtained
chromogenic substrate which can conveniently be used in kinetic studies
of
-lactamases and for the detection of these enzymes in bacterial
crude extracts or in chromatographic fractions during enzyme
purification. It can also be easily used in high-throughput screening
tests for the selection of new
-lactamase inactivators. Unfortunately, the absorption spectrum of the leaving group is such
that the contrast is not sufficient for the direct detection of
-lactamase-producing colonies on agar plates or on paper strip tests
or for the localization of
-lactamases after gel isoelectric focusing.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the Belgian government (grant PAI P 4/03), a TMR contract with the European Union (grant CT98-0232), and a grant from the Fonds National de la Rercherche Scientifique (Brussels, Belgium) for the purchase of the stopped-flow apparatus. C.B. was the beneficiary of Comoth (University of Liège) and FRIA (Brussels) predoctoral fellowships.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Centre for Protein Engineering, Institut de Chimie B6, Sart Tilman, 4000 Liège, Belgium. Phone: 32-4-3663549. Fax: 32-4-3663364. E-mail: mgalleni{at}ulg.ac.be.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bouillenne, F., A. Matagne, B. Joris, and J.-M. Frère. 2000. Technique for a rapid and efficient purification of the SHV-1 and PSE-2 beta-lactamases. J. Chromatogr. B Biomed. Sci. Appl. 737:261-265[CrossRef][Medline]. |
| 2. | Carfi, A., S. Pares, E. Duée, M. Galleni, C. Duez, J. M. Frère, and O. Dideberg. 1995. The 3-D structure of a zinc metallo-beta-lactamase from Bacillus cereus reveals a new type of protein fold. EMBO J. 1995. 14:4914-4921. |
| 3. | De Meester, F., B. Joris, G. Reckinger, C. Bellefroid-Bourguignon, J. M. Frère, and S. G. Waley. 1987. Automated analysis of enzyme inactivation phenomena. Application to beta-lactamases and DD-peptidases. Biochem. Pharmacol. 36:2393-2403[CrossRef][Medline]. |
| 4. | Faraci, W. S., and R. F. Pratt. 1985. Mechanism of inhibition of the PC1 beta-lactamase of Staphylococcus aureus by cephalosporins: importance of the 3'-leaving group. Biochemistry 24:903-910[CrossRef][Medline]. |
| 5. |
Franceschini, N.,
B. Caravelli,
J. D. Docquier,
M. Galleni,
J. M. Frère,
G. Amicosante, and G. M. Rossolini.
2000.
Purification and biochemical characterization of the VIM-1 metallo- -lactamase.
Antimicrob. Agents chemother.
44:3003-3007 |
| 6. | Frère, J. M., M. Leyh-Bouille, J. M. Ghuysen, M. Nieto, and H. R. Perkins. 1976. Exocellular DD-carboxypeptidases-transpeptidases from Streptomyces. Methods Enzymol. 45:610-636[Medline]. |
| 7. | Galleni, M., and J. M. Frère. 1988. A survey of the kinetic parameters of class C beta-lactamases. Biochem. J. 255:119-122[Medline]. |
| 8. | Granier, B., M. Jamin, M. Adam, M. Galleni, B. Lakaye, W. Zorzi, J. Granchamps, J. M. Wilkin, C. Fraipont, B. Joris, C. Duez, M. Nguyen-Distèche, J. Coyette, M. Leyh-Bouille, J. Dusart, L. Christiaens, J.-M. Frère, and J.-M. Ghuysen. 1994. Serine-type D-Ala-D-Ala peptidases and penicillin-binding proteins. Methods Enzymol. 244:249-266[Medline]. |
| 9. | Hernandez Valladares, M., A. Felici, G. Weber, H. W. Adolph, M. Zeppezauer, G. M. Rossolini, G. Amicosante, J.-M. Frère, and M. Galleni. 1997. Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-beta-lactamase activity and stability. Biochemistry 36:11534-11541[CrossRef][Medline]. |
| 10. | Ishii, Y., A. Ohno, H. Taguchi, S. Imajo, M. Ishiguro, and H. Matsuzawa. 1995. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli. Antimicrob. Agents Chemother. 39:2269-2275[Abstract]. |
| 11. |
Jones, R. N.,
H. W. Wilson,
W. J. Novick, Jr.,
A. L. Barry, and C. Thornsberry.
1982.
In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent.
J. Clin. Microbiol.
15:954-958 |
| 12. |
Laraki, N.,
N. Franceschini,
G. M. Rossolini,
P. Santucci,
C. Meunier,
E. de Pauw,
G. Amicosante,
J.-M. Frère, and M. Galleni.
1999.
Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-beta-lactamaseIMP-1 produced by Escherichia coli.
Antimicrob. Agents Chemother.
43:902-906 |
| 13. | Ledent, P., X. Raquet, B. Joris, J. Van Beeumen, and J. M. Frère. 1993. A comparative study of class-D beta-lactamases. Biochem. J. 292(Pt 2):555-562. |
| 14. | Leyh-Bouille, M., M. Nguyen-Distèche, S. Pirlot, A. Veithen, C. Bourguignon, and J. M. Ghuysen. 1986. Streptomyces K15 DD-peptidase-catalysed reactions with suicide beta-lactam carbonyl donors. Biochem. J. 235:177-182[Medline]. |
| 15. |
O'Callaghan, C. H.,
A. Morris,
S. M. Kirby, and A. H. Shingler.
1972.
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.
Antimicrob. Agents Chemother.
1:283-288 |
| 16. | Paul-Soto, R., M. Hernandez-Valladares, M. Galleni, R. Bauer, M. Zeppezauer, J.-M. Frère, and H.-W. Adolph. 1998. Mono- and binuclear Zn-beta-lactamase from Bacteroides fragilis: catalytic and structural roles of the zinc ions. FEBS Lett. 438:137-140[CrossRef][Medline]. |
| 17. | Raquet, X., J. Lamotte-Brasseur, E. Fonzé, S. Goussard, P. Courvalin, and J. M. Frère. 1994. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis. J. Mol. Biol. 244:625-639[CrossRef][Medline]. |
| 18. | Rossolini, G. M., N. Franceschini, M. L. Riccio, P. S. Mercuri, M. Perilli, M. Galleni, J. M. Frère, and G. Amicosante. 1998. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile. Biochem. J. 332:145-152. |
| 19. |
Swarén, P.,
L. Maveyraud,
X. Raquet,
S. Cabantous,
C. Duez,
J.-D. Pédelacq,
S. Mariotte-Boyer,
L. Mourey,
R. Labia,
M.-H. Nicolas-Chanoine,
P. Nordmann,
J.-M. Frère, and J.-P. Samama.
1998.
X-ray analysis of the NMC-A beta-lactamase at 1.64 Å resolution, a class A carbapenemase with broad substrate specificity.
J. Biol. Chem.
273:26714-26721 |
| 20. | Van der Linden, M. P. G., L. de Haan, O. Dideberg, and W. Keck. 1994. Site-directed mutagenesis of proposed active-site residues of penicillin-binding protein 5 from Escherichia coli. Biochem. J. 303:357-362. |
| 21. | Virden, R., A. F. Bristow, and R. H. Pain. 1975. The active site of penicillinase from Staphylococcus aureus PC1. Isolation of a specific covalent complex with the substrate quinacillin. Biochem. J. 149:397-401[Medline]. |
| 22. |
Voladri, R. K.,
D. L. Lakey,
S. H. Hennigan,
B. F. Menzies,
K. M. Edwards, and D. S. Kernodle.
1998.
Recombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis.
Antimicrob. Agents Chemother.
42:1375-1381 |
| 23. |
Yang, Y.,
B. A. Rasmussen, and K. Bush.
1992.
Biochemical characterization of an imipenem hydrolysing metallo -lactamase from Bacteroides fragilis TAL3636.
Antimicrob. Agents Chemother.
36:1155-1157 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |